Canon Korea has signed a medical device transaction contract with Johnson & Johnson MedTech Korea.Through the agreement, Canon Korea has acquired the rights to distribute Johnson & Johnson MedTech Korea's DePuy Synthes joint implants, which are used in orthopedics.The two companies held a business a
Pancreatic cancer is a very poorly treatable cancer. The cure rate (five-year survival rate) for pancreatic cancer is only 13.9 percent. The exact cause of pancreatic cancer, which is most common in people in their 60s and 70s, is still unknown.However, it is well known that smokers, people with dia
A 20-something job seeker surnamed Kang recently noticed that his hair was thinning, and his hairline became more noticeable than before. Kang thought it was due to the stress of his recent job search but couldn’t help but notice his hair falling out every time he washed and combed it. During a visi
Boston Scientific is recalling its medical device, a hemostasis valve-attached catheterizer, in Korea.According to the Ministry of Food and Drug Safety, Boston Scientific Korea submitted a recall plan for the hemostasis valve-attached catheterizer on Feb. 19 and began recalling the device.Sixty-two
Osang Healthcare said it recorded a 2,126 to 1 competition ratio in the company’s public share subscription for retail investors on Monday and Tuesday. The subscription deposit amounted to about 5.26 trillion won ($39.3 billion).Osang Healthcare's five-day demand forecast from Feb. 21 to 27 attracte
Patients and the pharmaceutical industry pay keen attention to whether the government will reimburse Enhertu (trastuzumab deruxtecan), for which drug price negotiations are underway with the National Health Insurance Service (NHIS) from April.Patient organizations have been pressuring the government
Professors at 33 Korean medical schools have filed a lawsuit to cancel the government's plan to increase in medical school student quotas. The defendants are the minister of health and welfare and the minister of education.Representatives of the faculty councils of 33 medical schools nationwide said
Severance Hospital said it recently marked a milestone of 500 liver cancer radioembolization procedures. Radioembolization for liver cancer, a minimally invasive treatment, involves the insertion of a catheter into the femoral artery of the leg, guiding it to the hepatic artery, and injecting micros
Seoul National University Bundang Hospital (SNUBH) has spearheaded the launch of a network aimed at timely treatment of severe and emergency cardiocerebrovascular diseases, such as stroke and myocardial infarction, within Gyeonggi Province.This initiative, part of the Ministry of Health and Welfare'
More than a month has passed since Enhertu (trastuzumab deruxtecan), a new breast cancer drug provided by Daiichi Sankyo Korea and AstraZeneca Korea, passed the Drug Reimbursement Evaluation Committee under the Health Insurance Review and Assessment Service (HIRA).However, news on its reimbursement
Bridge Biotherapeutics has reported a significant downturn in its financial performance for the year 2023.The company's annual revenue plummeted to 100 million won ($74,878), marking a drastic 96.7 percent decrease compared to the previous year.This downturn is attributed to the absence of additiona
Professor Park Yeong-min of the Department of Integrative Biological Sciences and Industry at Sejong University has been appointed the second CEO of the Korea Drug Development Fund (KDDF).The KDDF said Monday that CEO Park began his term with an inauguration ceremony with the KDDF staff.Park's term
Seoul National University Bundang Hospital (SNUBH) said Tuesday that its research team has developed “ECG Buddy,” an artificial intelligence (AI) application for emergency disease prediction that analyzes electrocardiogram (ECG) images to assess myocardial infarction and arrhythmia.The research team
Forty medical schools nationwide have requested to enroll an additional 3,401 students for the 2025 academic year, according to government officials on Tuesday.If the government accepts such requests, the medical school enrollment quota will more than double the current 3,058.The Ministry of Health
In a recent statement titled "Weight Management and CGM," the Korean Society for the Study of Obesity (KSSO) has voiced concerns over the unverified use of continuous glucose monitoring (CGM) devices for weight loss in individuals without diabetes.Such concerns come amid companies like Dr.Diary intr
The Korean medical device sector showcased its latest technologies and research achievements at the European Congress of Radiology 2024 (ECR 2024), held from Feb. 28 to last Suday in Vienna, Austria. ECR is recognized as one of the world's largest conferences in the field of radiology, alongside the
Cosmetic device maker ilooda said Monday that it had signed a settlement agreement with Serendia LLC to resolve a U.S. International Trade Commission (ITC) investigation.In March 2023, Serendia filed a complaint with the ITC, alleging ilooda’s infringement on its "invasive RF" patent.Invasive RF is
Binex, a Kosdaq-listed biopharmaceutical CDMO, has been subjected to a two-month suspension of sales operations for Bimo 5mg (ingredient: minoxidil), a hair loss treatment, for failing to submit necessary documents for the 2023 drug equivalence reevaluation.The product in question will not be availa
MSD's 15-valent pneumococcal conjugate vaccine (PCV), Vaxneuvance, will be used in Korea in earnest next month as part of the government’s pediatric national immunization program (NIP).MSD Korea said it had secured sufficient batches of Vaxneuvance to prepare for its full-scale launch.Vaxneuvance is
ProEn Therapeutics, which develops antibody-drug conjugates (ADCs), said Monday that it has completed attracting a strategic investment from Kolmar Korea Holdings.The investment amount was not disclosed per the agreement between the two companies.The investment is part of an open innovation program